[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100496243":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":25,"centralContacts":29,"locations":35,"responsibleParty":52,"collaborators":55,"id":61,"slug":62,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":10,"eligibilityCriteria":67,"healthyVolunteers":63,"sex":68,"minAge":69,"maxAge":70,"enrollmentInfo":71,"targetDuration":10,"studyType":74,"phases":10,"briefSummary":75,"conditions":76,"keywords":10,"overallStatus":38,"whyStopped":10,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Assiut University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Patient need NIV ventillation",null,"Patients will be eligible for enrolment if they are diagnosed with bronchiectasis and admitted to the respiratory intensive care unit (RICU); requiring ventilator support without invasive mechanical ventilation and will need NIV",[13],"Drug: bi-level ventillation",{"label":15,"type":10,"description":16,"interventionNames":10},"patient need HFNC","Patients will be eligible for enrolment if they are diagnosed with bronchiectasis and admitted to the respiratory intensive care unit (RICU); requiring ventilator support without invasive mechanical ventilation and will need HFNC",[18],{"type":19,"name":20,"description":21,"armGroupLabels":22,"otherNames":23},"DRUG","bi-level ventillation","non-invasive mechanical ventilation",[9],[24],"HFNC",[26],{"name":27,"affiliation":5,"role":28},"Ahmad M. Shaddad","PRINCIPAL_INVESTIGATOR",[30],{"name":31,"role":32,"phone":33,"phoneExt":10,"email":34},"ahmad shaddad, MD","CONTACT","+201111171930","shaddad_ahmad@yahoo.com",[36],{"facility":37,"status":38,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"Assiut University-Faculty of medicine","RECRUITING","Asyut","Asyut Governorate","71515","Egypt","EG",{"type":45,"coordinates":46},"Point",[47,48],31.18368,27.18096,{"lat":48,"lon":47},[51],{"name":31,"role":32,"phone":33,"phoneExt":10,"email":34},{"type":28,"investigatorFullName":53,"investigatorTitle":54,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Ahmad Shaddad","lecturer of pulmonology",[56,59],{"name":57,"class":58},"WGEKHALEEL","UNKNOWN",{"name":60,"class":58},"AARMHUSSIEN","100496243","hfnc-in-management-of-bronchiectasis-exacerbation-100496243",false,"NCT05741697","HFNC in Management of Bronchiectasis Exacerbation","High Flow Nasal Cannula Versus Non-invasive Ventilation in Managing Acute Exacerbation of Bronchiectasis Patients","Inclusion Criteria:\n\n* Patients will be eligible for enrolment if diagnosed with bronchiectasis and admitted to the respiratory intensive care unit (RICU), requiring ventilator support without invasive mechanical ventilation.\n\nExclusion Criteria:\n\n* Age: less than 18 years. Patients with post-arrest encephalopathy. Patient with the previous tracheotomy. Patients who received invasive ventilatory support. Patients with end-organ failure.","ALL","18 Years","80 Years",{"count":72,"type":73},20,"ESTIMATED","OBSERVATIONAL","Patients with Bronchiectasis experience exacerbations with hypercapnic respiratory failure associated with an increased respiratory workload that may require intensive care unit (ICU) admission due to the inability of the respiratory muscles to compensate for increased demand. These exacerbations are frequently treated with noninvasive ventilation (NIV).",[77],"Bronchiectasis","2026-04-26",{"date":80,"type":81},"2026-04-30","ACTUAL",{"date":83,"type":81},"2023-03-01",{"date":85,"type":73},"2026-10-01",{"name":5,"class":6},1]